Pfizer CEO Weighs In on When a COVID-19 Antiviral Drug Could Be Available
1 sourceUpdated Apr 27, 2021
Pfizer CEO Albert Bourla is predicting a COVID-19 antiviral drug could be availably by the end of the year if “all goes well.” Bourla said during an appearance on CNBC the focus is on the oral because “it provides…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup

